IL-23/IL-23R: potential mediator of intestinal tumor progression from adenomatous polyps to colorectal carcinoma
Authors:
- 6 May 2011
- journal article
- research article
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 26 (12) , 1511-1518
Abstract
Interleukin 23 (IL-23) affects tumor growth by regulating Th cells and plays a vital role in immunosuppression in tumor tissues. However, whether tumor cells are IL-23R positive or whether IL-23 has the potential to influence the growth of cancer cells directly remains unclear. The aim of this study was to clarify the molecular expression patterns of IL-23, IL-23R, and Forkhead box P3 (FOXP3) in normal tissues adjacent to cancer, in intestinal polyps (IP), and in colorectal carcinoma (CRC), and to infer the relationship between the expression patterns of these three molecules and the progress of intestinal tumors from adenomatous polyps to colorectal cancer.Keywords
This publication has 27 references indexed in Scilit:
- Interleukin-23 Drives Intestinal Inflammation through Direct Activity on T CellsImmunity, 2010
- Foxp3 Expression in p53-dependent DNA Damage ResponsesJournal of Biological Chemistry, 2010
- Regulation of the IL-23 and IL-12 Balance by Stat3 Signaling in the Tumor MicroenvironmentCancer Cell, 2009
- Systemic Administration of IL-23 Induces Potent Antitumor Immunity Primarily Mediated through Th1-Type Response in Association with the Endogenously Expressed IL-12The Journal of Immunology, 2007
- IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2–dependent mechanisms with implications for psoriasis pathogenesisJournal of Experimental Medicine, 2006
- Interleukin-23 drives innate and T cell–mediated intestinal inflammationJournal of Experimental Medicine, 2006
- IL-23 plays a key role inHelicobacter hepaticus–induced T cell–dependent colitisJournal of Experimental Medicine, 2006
- Regulatory T cells in cancerBlood, 2006
- IL-23 promotes tumour incidence and growthNature, 2006
- IL-23 is essential for T cell–mediated colitis and promotes inflammation via IL-17 and IL-6Journal of Clinical Investigation, 2006